Virus-mediated killing of cells that lack p53 activity

Area of Science:

• Molecular Oncology
• Virology
• Cell Cycle Regulation

Background:

• Targeting cancer cells lacking p53 is a key goal in oncology.
• Current therapies often rely on DNA damage, which can be ineffective in p53-deficient cells.
• The p53 protein normally prevents cell death after DNA damage by arresting the cell cycle.

Purpose of the Study:

• To investigate the potential of adeno-associated virus (AAV) to selectively induce apoptosis in cancer cells lacking p53.
• To understand the mechanism by which AAV affects cells with and without functional p53.

Main Methods:

• Treatment of cells with varying p53 status using AAV.
• Analysis of cell viability, cell cycle progression, p53 activity, p21 levels, and CDC25C degradation.
• Evaluation of AAV's effect on tumor growth in a mouse model.

Main Results:

• AAV selectively induced apoptosis in cells lacking active p53.
• Cells with intact p53 underwent G2 cell cycle arrest, not death.
• Neither cell killing nor arrest depended on AAV-encoded proteins, but rather on the unique structure of AAV DNA triggering a DNA damage response.
• AAV demonstrated inhibition of tumor growth in mice.

Conclusions:

• AAV DNA can trigger a DNA damage response that selectively eliminates p53-deficient cells.
• This mechanism offers a novel therapeutic strategy for cancers with compromised p53 function.
• Viruses can be utilized to deliver structurally unique DNA, inducing targeted cell death without direct DNA damage.